208 related articles for article (PubMed ID: 31665257)
21. Myocardial analysis from routine 4D cardiac-CT to predict reverse remodeling and clinical outcomes after transcatheter aortic valve implantation.
Bernhard B; Schütze J; Leib ZL; Spano G; Boscolo Berto M; Bakula A; Tomii D; Shiri I; Brugger N; De Marchi S; Reineke D; Dobner S; Heg D; Praz F; Lanz J; Stortecky S; Pilgrim T; Windecker S; Gräni C
Eur J Radiol; 2024 Jun; 175():111425. PubMed ID: 38490128
[TBL] [Abstract][Full Text] [Related]
22. Quantification of hypo-attenuated leaflet thickening after transcatheter aortic valve implantation: clinical relevance of hypo-attenuated leaflet thickening volume.
Karády J; Apor A; Nagy AI; Kolossváry M; Bartykowszki A; Szilveszter B; Simon J; Molnár L; Jermendy ÁL; Panajotu A; Suhai FI; Varga A; Rajani R; Maurovich-Horvat P; Merkely B
Eur Heart J Cardiovasc Imaging; 2020 Dec; 21(12):1395-1404. PubMed ID: 32756984
[TBL] [Abstract][Full Text] [Related]
23. Left ventricular global systolic longitudinal deformation and prognosis 1 year after femoral and apical transcatheter aortic valve implantation.
Løgstrup BB; Andersen HR; Thuesen L; Christiansen EH; Terp K; Klaaborg KE; Poulsen SH
J Am Soc Echocardiogr; 2013 Mar; 26(3):246-54. PubMed ID: 23306032
[TBL] [Abstract][Full Text] [Related]
24. Transcatheter aortic valve implantation in severe aortic stenosis does not necessarily reverse left ventricular myocardial damage: data of long-term follow-up.
Myon F; Marut B; Kosmala W; Auffret V; Leurent G; L'official G; Curtis E; Le Breton H; Oger E; Donal E
Eur Heart J Cardiovasc Imaging; 2024 May; 25(6):821-828. PubMed ID: 38236150
[TBL] [Abstract][Full Text] [Related]
25. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
[TBL] [Abstract][Full Text] [Related]
26. Coagulation derangement and risk factors for valve thrombosis following transcatheter aortic valve implantation.
Patterson T; Hurrell H; Lee J; Esposito G; Dutta U; Grapsa J; Aroney N; Ahmed-Jushuf F; Allen C; Rajani R; Preston R; Young C; Lucchese G; Parmar K; Hunt B; Prendergast BD; Redwood SR
Open Heart; 2021 Jun; 8(1):. PubMed ID: 34127530
[TBL] [Abstract][Full Text] [Related]
27. Early and Late Leaflet Thrombosis After Transcatheter Aortic Valve Replacement.
Yanagisawa R; Tanaka M; Yashima F; Arai T; Jinzaki M; Shimizu H; Fukuda K; Watanabe Y; Naganuma T; Higashimori A; Mizutani K; Araki M; Tada N; Yamanaka F; Otsuka T; Yamamoto M; Hayashida K
Circ Cardiovasc Interv; 2019 Feb; 12(2):e007349. PubMed ID: 30732472
[TBL] [Abstract][Full Text] [Related]
28. Bioprosthesis leaflet thrombosis following self-expanding valve-in-valve transcatheter aortic valve replacement in patient taking factor Xa inhibitor and warfarin: A case report.
Buchanan KD; Alraies MC; Weissman G; Ben-Dor I; Satler LF; Waksman R
Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):29-32. PubMed ID: 29066342
[TBL] [Abstract][Full Text] [Related]
29. Commissural misalignment independently predicts leaflet thrombosis after transcatheter aortic valve implantation.
Jung S; Ammon F; Smolka S; Moshage M; Marwan M; Achenbach S
Clin Res Cardiol; 2024 Jan; 113(1):29-37. PubMed ID: 37022472
[TBL] [Abstract][Full Text] [Related]
30. Interaction between sex and left ventricular reverse remodeling and its association with outcomes after transcatheter aortic valve implantation.
Kuneman JH; Butcher SC; Stassen J; Singh GK; Pio SM; van der Kley F; Ajmone Marsan N; Knuuti J; Bax JJ; Delgado V
Int J Cardiovasc Imaging; 2022 Sep; 38(9):1973-1985. PubMed ID: 37726606
[TBL] [Abstract][Full Text] [Related]
31. Left ventricular reverse remodeling in percutaneous and surgical aortic bioprostheses: an echocardiographic study.
Giannini C; Petronio AS; Nardi C; De Carlo M; Guarracino F; Delle Donne MG; Talini E; Minzioni G; Bortolotti U; Cucco C; Marzilli M; Di Bello V
J Am Soc Echocardiogr; 2011 Jan; 24(1):28-36. PubMed ID: 20850946
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of pre-procedural left ventricular strain for clinical events after transcatheter aortic valve implantation.
Suzuki-Eguchi N; Murata M; Itabashi Y; Shirakawa K; Fukuda M; Endo J; Tsuruta H; Arai T; Hayashida K; Shimizu H; Fukuda K
PLoS One; 2018; 13(10):e0205190. PubMed ID: 30308001
[TBL] [Abstract][Full Text] [Related]
33. Acute Reverse Remodelling After Transcatheter Aortic Valve Implantation: A Link Between Myocardial Fibrosis and Left Ventricular Mass Regression.
Dobson LE; Musa TA; Uddin A; Fairbairn TA; Swoboda PP; Erhayiem B; Foley J; Garg P; Haaf P; Fent GJ; Malkin CJ; Blackman DJ; Plein S; Greenwood JP
Can J Cardiol; 2016 Dec; 32(12):1411-1418. PubMed ID: 27523272
[TBL] [Abstract][Full Text] [Related]
34. Assessment of left ventricular function with tissue Doppler echocardiography and of B-type natriuretic peptide levels in patients undergoing transcatheter aortic valve implantation.
Yüksel IO; Arslan S; Cagirci G; Koklu E; Ureyen CM; Bayar N; Kucukseymen S; Kus G; Guven R
Rev Port Cardiol; 2017 May; 36(5):377-383. PubMed ID: 28495181
[TBL] [Abstract][Full Text] [Related]
35. Early regression of left ventricular mass associated with diastolic improvement after transcatheter aortic valve implantation.
Vizzardi E; D'Aloia A; Fiorina C; Bugatti S; Parrinello G; De Carlo M; Giannini C; Di Bello V; Petronio AS; Curello S; Ettori F; Dei Cas L
J Am Soc Echocardiogr; 2012 Oct; 25(10):1091-8. PubMed ID: 22819229
[TBL] [Abstract][Full Text] [Related]
36. Myocardial gene expression of microRNA-133a and myosin heavy and light chains, in conjunction with clinical parameters, predict regression of left ventricular hypertrophy after valve replacement in patients with aortic stenosis.
Villar AV; Merino D; Wenner M; Llano M; Cobo M; Montalvo C; García R; Martín-Durán R; Hurlé JM; Hurlé MA; Nistal JF
Heart; 2011 Jul; 97(14):1132-7. PubMed ID: 21586423
[TBL] [Abstract][Full Text] [Related]
37. Influence of prosthesis-related factors on the occurrence of early leaflet thrombosis after transcatheter aortic valve implantation.
Breitbart P; Pache G; Minners J; Hein M; Schröfel H; Neumann FJ; Ruile P
Eur Heart J Cardiovasc Imaging; 2020 Oct; 21(10):1082-1089. PubMed ID: 32588038
[TBL] [Abstract][Full Text] [Related]
38. Acute left ventricle diastolic function improvement after transcatheter aortic valve implantation.
Gonçalves A; Marcos-Alberca P; Almeria C; Feltes G; Rodríguez E; Hernández-Antolín RA; Garcia E; Maroto L; Fernandez Perez C; Silva Cardoso JC; Macaya C; Zamorano JL
Eur J Echocardiogr; 2011 Oct; 12(10):790-7. PubMed ID: 21865229
[TBL] [Abstract][Full Text] [Related]
39. Myocardial contractility recovery following acute pressure unloading after transcatheter aortic valve intervention (TAVI) in patients with severe aortic stenosis and different left ventricular geometry: a multilayer longitudinal strain echocardiographicanalysis.
Cimino S; Monosilio S; Luongo F; Neccia M; Birtolo LI; Salvi N; Filomena D; Mancone M; Fedele F; Agati L; Maestrini V
Int J Cardiovasc Imaging; 2021 Mar; 37(3):965-970. PubMed ID: 33251555
[TBL] [Abstract][Full Text] [Related]
40. Value of CT signs and measurements as a predictor of pulmonary hypertension and mortality in symptomatic severe aortic valve stenosis.
Eberhard M; Mastalerz M; Pavicevic J; Frauenfelder T; Nietlispach F; Maisano F; Tanner FC; Nguyen-Kim TDL
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1637-1651. PubMed ID: 28550588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
